 | • レポートコード：MRC2-11QY05031 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、158ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料はウイルス性肝炎・レトロウイルス診断検査のグローバル市場について調査・分析したレポートです。種類別（急性肝炎、慢性肝炎）市場規模、用途別（病院、クリニック、訪問看護）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別ウイルス性肝炎・レトロウイルス診断検査の競争状況、市場シェア ・世界のウイルス性肝炎・レトロウイルス診断検査市場：種類別市場規模 2015年-2020年（急性肝炎、慢性肝炎） ・世界のウイルス性肝炎・レトロウイルス診断検査市場：種類別市場規模予測 2021年-2026年（急性肝炎、慢性肝炎） ・世界のウイルス性肝炎・レトロウイルス診断検査市場：用途別市場規模 2015年-2020年（病院、クリニック、訪問看護） ・世界のウイルス性肝炎・レトロウイルス診断検査市場：用途別市場規模予測 2021年-2026年（病院、クリニック、訪問看護） ・北米のウイルス性肝炎・レトロウイルス診断検査市場分析：米国、カナダ ・ヨーロッパのウイルス性肝炎・レトロウイルス診断検査市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアのウイルス性肝炎・レトロウイルス診断検査市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米のウイルス性肝炎・レトロウイルス診断検査市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカのウイルス性肝炎・レトロウイルス診断検査市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Abbott Diagnostics、Abbott、Chembio、DiaSorin、Roche Diagnostics、Amkay Products、AOV International、Apothecaries Sundries Manufacturing、Beckman Coulter、BD、Bhat Bio-tech、BioMerieux、Bioneovan、Bio-Rad、Cepheid、Enzo Biochem、Fujirebio、Gemc Technology、Grifols、Hangzhou Deangel Biological Engineering、Hangzhou Heo Bio-Tech、Hologic、Horiba、Innovation Biotech、Jaksh Enterprises、Krishco Medical Products ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Diagnostics tests for viral hepatitis and retrovirus help in screening, diagnosing, and managing diseases in humans. The tests are usually performed in the laboratory under controlled environment. In hepatitis and retrovirus infections, the diagnostic tests provide a valuable health status of patients without having a direct therapeutic effect. Hence, they play a significant role in supporting decision-making in clinical conditions. Advances in diagnostic testing systems and assays have led to the development of self-testing, which are easy to perform and convenient for both medical professionals and patients. The diagnostic tests for viral hepatitis and retrovirus can be carried out in hospitals, clinics, or at home.
QYResearch analysts estimate upcoming trends, like the augmented demand for biomarker-based tests, to spur market growth during the forecast period. Biomarkers aid in the detection of a disease and are useful for high-growth clinical areas like infectious diseases. Since biomarkers are envisaged to replace conventional drug therapeutics in the future, vendors are increasingly developing cost-effective biomarker-based tests to augment their market penetration.
Market Analysis and Insights: Global Viral Hepatitis and Retrovirus Diagnostic Tests Market
The global Viral Hepatitis and Retrovirus Diagnostic Tests market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Viral Hepatitis and Retrovirus Diagnostic Tests Scope and Market Size
Viral Hepatitis and Retrovirus Diagnostic Tests market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Viral Hepatitis and Retrovirus Diagnostic Tests market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Abbott Diagnostics
Abbott
Chembio
DiaSorin
Roche Diagnostics
Amkay Products
AOV International
Apothecaries Sundries Manufacturing
Beckman Coulter
BD
Bhat Bio-tech
BioMerieux
Bioneovan
Bio-Rad
Cepheid
Enzo Biochem
Fujirebio
Gemc Technology
Grifols
Hangzhou Deangel Biological Engineering
Hangzhou Heo Bio-Tech
Hologic
Horiba
Innovation Biotech
Jaksh Enterprises
Krishco Medical Products
Market segment by Type, the product can be split into
Acute Hepatitis
Chronic Hepatitis
Market segment by Application, split into
Hospitals
Clinics
Home Nursing
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Viral Hepatitis and Retrovirus Diagnostic Tests Revenue
1.4 Market by Type
1.4.1 Global Viral Hepatitis and Retrovirus Diagnostic Tests Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Acute Hepatitis
1.4.3 Chronic Hepatitis
1.5 Market by Application
1.5.1 Global Viral Hepatitis and Retrovirus Diagnostic Tests Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Home Nursing
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Viral Hepatitis and Retrovirus Diagnostic Tests Market Perspective (2015-2026)
2.2 Global Viral Hepatitis and Retrovirus Diagnostic Tests Growth Trends by Regions
2.2.1 Viral Hepatitis and Retrovirus Diagnostic Tests Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Viral Hepatitis and Retrovirus Diagnostic Tests Historic Market Share by Regions (2015-2020)
2.2.3 Viral Hepatitis and Retrovirus Diagnostic Tests Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Viral Hepatitis and Retrovirus Diagnostic Tests Market Growth Strategy
2.3.6 Primary Interviews with Key Viral Hepatitis and Retrovirus Diagnostic Tests Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Viral Hepatitis and Retrovirus Diagnostic Tests Players by Market Size
3.1.1 Global Top Viral Hepatitis and Retrovirus Diagnostic Tests Players by Revenue (2015-2020)
3.1.2 Global Viral Hepatitis and Retrovirus Diagnostic Tests Revenue Market Share by Players (2015-2020)
3.1.3 Global Viral Hepatitis and Retrovirus Diagnostic Tests Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Viral Hepatitis and Retrovirus Diagnostic Tests Market Concentration Ratio
3.2.1 Global Viral Hepatitis and Retrovirus Diagnostic Tests Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Viral Hepatitis and Retrovirus Diagnostic Tests Revenue in 2019
3.3 Viral Hepatitis and Retrovirus Diagnostic Tests Key Players Head office and Area Served
3.4 Key Players Viral Hepatitis and Retrovirus Diagnostic Tests Product Solution and Service
3.5 Date of Enter into Viral Hepatitis and Retrovirus Diagnostic Tests Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Viral Hepatitis and Retrovirus Diagnostic Tests Historic Market Size by Type (2015-2020)
4.2 Global Viral Hepatitis and Retrovirus Diagnostic Tests Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Viral Hepatitis and Retrovirus Diagnostic Tests Market Size by Application (2015-2020)
5.2 Global Viral Hepatitis and Retrovirus Diagnostic Tests Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Viral Hepatitis and Retrovirus Diagnostic Tests Market Size (2015-2020)
6.2 Viral Hepatitis and Retrovirus Diagnostic Tests Key Players in North America (2019-2020)
6.3 North America Viral Hepatitis and Retrovirus Diagnostic Tests Market Size by Type (2015-2020)
6.4 North America Viral Hepatitis and Retrovirus Diagnostic Tests Market Size by Application (2015-2020)
7 Europe
7.1 Europe Viral Hepatitis and Retrovirus Diagnostic Tests Market Size (2015-2020)
7.2 Viral Hepatitis and Retrovirus Diagnostic Tests Key Players in Europe (2019-2020)
7.3 Europe Viral Hepatitis and Retrovirus Diagnostic Tests Market Size by Type (2015-2020)
7.4 Europe Viral Hepatitis and Retrovirus Diagnostic Tests Market Size by Application (2015-2020)
8 China
8.1 China Viral Hepatitis and Retrovirus Diagnostic Tests Market Size (2015-2020)
8.2 Viral Hepatitis and Retrovirus Diagnostic Tests Key Players in China (2019-2020)
8.3 China Viral Hepatitis and Retrovirus Diagnostic Tests Market Size by Type (2015-2020)
8.4 China Viral Hepatitis and Retrovirus Diagnostic Tests Market Size by Application (2015-2020)
9 Japan
9.1 Japan Viral Hepatitis and Retrovirus Diagnostic Tests Market Size (2015-2020)
9.2 Viral Hepatitis and Retrovirus Diagnostic Tests Key Players in Japan (2019-2020)
9.3 Japan Viral Hepatitis and Retrovirus Diagnostic Tests Market Size by Type (2015-2020)
9.4 Japan Viral Hepatitis and Retrovirus Diagnostic Tests Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Viral Hepatitis and Retrovirus Diagnostic Tests Market Size (2015-2020)
10.2 Viral Hepatitis and Retrovirus Diagnostic Tests Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Viral Hepatitis and Retrovirus Diagnostic Tests Market Size by Type (2015-2020)
10.4 Southeast Asia Viral Hepatitis and Retrovirus Diagnostic Tests Market Size by Application (2015-2020)
11 India
11.1 India Viral Hepatitis and Retrovirus Diagnostic Tests Market Size (2015-2020)
11.2 Viral Hepatitis and Retrovirus Diagnostic Tests Key Players in India (2019-2020)
11.3 India Viral Hepatitis and Retrovirus Diagnostic Tests Market Size by Type (2015-2020)
11.4 India Viral Hepatitis and Retrovirus Diagnostic Tests Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Viral Hepatitis and Retrovirus Diagnostic Tests Market Size (2015-2020)
12.2 Viral Hepatitis and Retrovirus Diagnostic Tests Key Players in Central & South America (2019-2020)
12.3 Central & South America Viral Hepatitis and Retrovirus Diagnostic Tests Market Size by Type (2015-2020)
12.4 Central & South America Viral Hepatitis and Retrovirus Diagnostic Tests Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Abbott Diagnostics
13.1.1 Abbott Diagnostics Company Details
13.1.2 Abbott Diagnostics Business Overview
13.1.3 Abbott Diagnostics Viral Hepatitis and Retrovirus Diagnostic Tests Introduction
13.1.4 Abbott Diagnostics Revenue in Viral Hepatitis and Retrovirus Diagnostic Tests Business (2015-2020))
13.1.5 Abbott Diagnostics Recent Development
13.2 Abbott
13.2.1 Abbott Company Details
13.2.2 Abbott Business Overview
13.2.3 Abbott Viral Hepatitis and Retrovirus Diagnostic Tests Introduction
13.2.4 Abbott Revenue in Viral Hepatitis and Retrovirus Diagnostic Tests Business (2015-2020)
13.2.5 Abbott Recent Development
13.3 Chembio
13.3.1 Chembio Company Details
13.3.2 Chembio Business Overview
13.3.3 Chembio Viral Hepatitis and Retrovirus Diagnostic Tests Introduction
13.3.4 Chembio Revenue in Viral Hepatitis and Retrovirus Diagnostic Tests Business (2015-2020)
13.3.5 Chembio Recent Development
13.4 DiaSorin
13.4.1 DiaSorin Company Details
13.4.2 DiaSorin Business Overview
13.4.3 DiaSorin Viral Hepatitis and Retrovirus Diagnostic Tests Introduction
13.4.4 DiaSorin Revenue in Viral Hepatitis and Retrovirus Diagnostic Tests Business (2015-2020)
13.4.5 DiaSorin Recent Development
13.5 Roche Diagnostics
13.5.1 Roche Diagnostics Company Details
13.5.2 Roche Diagnostics Business Overview
13.5.3 Roche Diagnostics Viral Hepatitis and Retrovirus Diagnostic Tests Introduction
13.5.4 Roche Diagnostics Revenue in Viral Hepatitis and Retrovirus Diagnostic Tests Business (2015-2020)
13.5.5 Roche Diagnostics Recent Development
13.6 Amkay Products
13.6.1 Amkay Products Company Details
13.6.2 Amkay Products Business Overview
13.6.3 Amkay Products Viral Hepatitis and Retrovirus Diagnostic Tests Introduction
13.6.4 Amkay Products Revenue in Viral Hepatitis and Retrovirus Diagnostic Tests Business (2015-2020)
13.6.5 Amkay Products Recent Development
13.7 AOV International
13.7.1 AOV International Company Details
13.7.2 AOV International Business Overview
13.7.3 AOV International Viral Hepatitis and Retrovirus Diagnostic Tests Introduction
13.7.4 AOV International Revenue in Viral Hepatitis and Retrovirus Diagnostic Tests Business (2015-2020)
13.7.5 AOV International Recent Development
13.8 Apothecaries Sundries Manufacturing
13.8.1 Apothecaries Sundries Manufacturing Company Details
13.8.2 Apothecaries Sundries Manufacturing Business Overview
13.8.3 Apothecaries Sundries Manufacturing Viral Hepatitis and Retrovirus Diagnostic Tests Introduction
13.8.4 Apothecaries Sundries Manufacturing Revenue in Viral Hepatitis and Retrovirus Diagnostic Tests Business (2015-2020)
13.8.5 Apothecaries Sundries Manufacturing Recent Development
13.9 Beckman Coulter
13.9.1 Beckman Coulter Company Details
13.9.2 Beckman Coulter Business Overview
13.9.3 Beckman Coulter Viral Hepatitis and Retrovirus Diagnostic Tests Introduction
13.9.4 Beckman Coulter Revenue in Viral Hepatitis and Retrovirus Diagnostic Tests Business (2015-2020)
13.9.5 Beckman Coulter Recent Development
13.10 BD
13.10.1 BD Company Details
13.10.2 BD Business Overview
13.10.3 BD Viral Hepatitis and Retrovirus Diagnostic Tests Introduction
13.10.4 BD Revenue in Viral Hepatitis and Retrovirus Diagnostic Tests Business (2015-2020)
13.10.5 BD Recent Development
13.11 Bhat Bio-tech
10.11.1 Bhat Bio-tech Company Details
10.11.2 Bhat Bio-tech Business Overview
10.11.3 Bhat Bio-tech Viral Hepatitis and Retrovirus Diagnostic Tests Introduction
10.11.4 Bhat Bio-tech Revenue in Viral Hepatitis and Retrovirus Diagnostic Tests Business (2015-2020)
10.11.5 Bhat Bio-tech Recent Development
13.12 BioMerieux
10.12.1 BioMerieux Company Details
10.12.2 BioMerieux Business Overview
10.12.3 BioMerieux Viral Hepatitis and Retrovirus Diagnostic Tests Introduction
10.12.4 BioMerieux Revenue in Viral Hepatitis and Retrovirus Diagnostic Tests Business (2015-2020)
10.12.5 BioMerieux Recent Development
13.13 Bioneovan
10.13.1 Bioneovan Company Details
10.13.2 Bioneovan Business Overview
10.13.3 Bioneovan Viral Hepatitis and Retrovirus Diagnostic Tests Introduction
10.13.4 Bioneovan Revenue in Viral Hepatitis and Retrovirus Diagnostic Tests Business (2015-2020)
10.13.5 Bioneovan Recent Development
13.14 Bio-Rad
10.14.1 Bio-Rad Company Details
10.14.2 Bio-Rad Business Overview
10.14.3 Bio-Rad Viral Hepatitis and Retrovirus Diagnostic Tests Introduction
10.14.4 Bio-Rad Revenue in Viral Hepatitis and Retrovirus Diagnostic Tests Business (2015-2020)
10.14.5 Bio-Rad Recent Development
13.15 Cepheid
10.15.1 Cepheid Company Details
10.15.2 Cepheid Business Overview
10.15.3 Cepheid Viral Hepatitis and Retrovirus Diagnostic Tests Introduction
10.15.4 Cepheid Revenue in Viral Hepatitis and Retrovirus Diagnostic Tests Business (2015-2020)
10.15.5 Cepheid Recent Development
13.16 Enzo Biochem
10.16.1 Enzo Biochem Company Details
10.16.2 Enzo Biochem Business Overview
10.16.3 Enzo Biochem Viral Hepatitis and Retrovirus Diagnostic Tests Introduction
10.16.4 Enzo Biochem Revenue in Viral Hepatitis and Retrovirus Diagnostic Tests Business (2015-2020)
10.16.5 Enzo Biochem Recent Development
13.17 Fujirebio
10.17.1 Fujirebio Company Details
10.17.2 Fujirebio Business Overview
10.17.3 Fujirebio Viral Hepatitis and Retrovirus Diagnostic Tests Introduction
10.17.4 Fujirebio Revenue in Viral Hepatitis and Retrovirus Diagnostic Tests Business (2015-2020)
10.17.5 Fujirebio Recent Development
13.18 Gemc Technology
10.18.1 Gemc Technology Company Details
10.18.2 Gemc Technology Business Overview
10.18.3 Gemc Technology Viral Hepatitis and Retrovirus Diagnostic Tests Introduction
10.18.4 Gemc Technology Revenue in Viral Hepatitis and Retrovirus Diagnostic Tests Business (2015-2020)
10.18.5 Gemc Technology Recent Development
13.19 Grifols
10.19.1 Grifols Company Details
10.19.2 Grifols Business Overview
10.19.3 Grifols Viral Hepatitis and Retrovirus Diagnostic Tests Introduction
10.19.4 Grifols Revenue in Viral Hepatitis and Retrovirus Diagnostic Tests Business (2015-2020)
10.19.5 Grifols Recent Development
13.20 Hangzhou Deangel Biological Engineering
10.20.1 Hangzhou Deangel Biological Engineering Company Details
10.20.2 Hangzhou Deangel Biological Engineering Business Overview
10.20.3 Hangzhou Deangel Biological Engineering Viral Hepatitis and Retrovirus Diagnostic Tests Introduction
10.20.4 Hangzhou Deangel Biological Engineering Revenue in Viral Hepatitis and Retrovirus Diagnostic Tests Business (2015-2020)
10.20.5 Hangzhou Deangel Biological Engineering Recent Development
13.21 Hangzhou Heo Bio-Tech
10.21.1 Hangzhou Heo Bio-Tech Company Details
10.21.2 Hangzhou Heo Bio-Tech Business Overview
10.21.3 Hangzhou Heo Bio-Tech Viral Hepatitis and Retrovirus Diagnostic Tests Introduction
10.21.4 Hangzhou Heo Bio-Tech Revenue in Viral Hepatitis and Retrovirus Diagnostic Tests Business (2015-2020)
10.21.5 Hangzhou Heo Bio-Tech Recent Development
13.22 Hologic
10.22.1 Hologic Company Details
10.22.2 Hologic Business Overview
10.22.3 Hologic Viral Hepatitis and Retrovirus Diagnostic Tests Introduction
10.22.4 Hologic Revenue in Viral Hepatitis and Retrovirus Diagnostic Tests Business (2015-2020)
10.22.5 Hologic Recent Development
13.23 Horiba
10.23.1 Horiba Company Details
10.23.2 Horiba Business Overview
10.23.3 Horiba Viral Hepatitis and Retrovirus Diagnostic Tests Introduction
10.23.4 Horiba Revenue in Viral Hepatitis and Retrovirus Diagnostic Tests Business (2015-2020)
10.23.5 Horiba Recent Development
13.24 Innovation Biotech
10.24.1 Innovation Biotech Company Details
10.24.2 Innovation Biotech Business Overview
10.24.3 Innovation Biotech Viral Hepatitis and Retrovirus Diagnostic Tests Introduction
10.24.4 Innovation Biotech Revenue in Viral Hepatitis and Retrovirus Diagnostic Tests Business (2015-2020)
10.24.5 Innovation Biotech Recent Development
13.25 Jaksh Enterprises
10.25.1 Jaksh Enterprises Company Details
10.25.2 Jaksh Enterprises Business Overview
10.25.3 Jaksh Enterprises Viral Hepatitis and Retrovirus Diagnostic Tests Introduction
10.25.4 Jaksh Enterprises Revenue in Viral Hepatitis and Retrovirus Diagnostic Tests Business (2015-2020)
10.25.5 Jaksh Enterprises Recent Development
13.26 Krishco Medical Products
10.26.1 Krishco Medical Products Company Details
10.26.2 Krishco Medical Products Business Overview
10.26.3 Krishco Medical Products Viral Hepatitis and Retrovirus Diagnostic Tests Introduction
10.26.4 Krishco Medical Products Revenue in Viral Hepatitis and Retrovirus Diagnostic Tests Business (2015-2020)
10.26.5 Krishco Medical Products Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Viral Hepatitis and Retrovirus Diagnostic Tests Key Market Segments
Table 2. Key Players Covered: Ranking by Viral Hepatitis and Retrovirus Diagnostic Tests Revenue
Table 3. Ranking of Global Top Viral Hepatitis and Retrovirus Diagnostic Tests Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Viral Hepatitis and Retrovirus Diagnostic Tests Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Acute Hepatitis
Table 6. Key Players of Chronic Hepatitis
Table 7. Global Viral Hepatitis and Retrovirus Diagnostic Tests Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 8. Global Viral Hepatitis and Retrovirus Diagnostic Tests Market Size by Regions (US$ Million): 2020 VS 2026
Table 9. Global Viral Hepatitis and Retrovirus Diagnostic Tests Market Size by Regions (2015-2020) (US$ Million)
Table 10. Global Viral Hepatitis and Retrovirus Diagnostic Tests Market Share by Regions (2015-2020)
Table 11. Global Viral Hepatitis and Retrovirus Diagnostic Tests Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 12. Global Viral Hepatitis and Retrovirus Diagnostic Tests Market Share by Regions (2021-2026)
Table 13. Market Top Trends
Table 14. Key Drivers: Impact Analysis
Table 15. Key Challenges
Table 16. Viral Hepatitis and Retrovirus Diagnostic Tests Market Growth Strategy
Table 17. Main Points Interviewed from Key Viral Hepatitis and Retrovirus Diagnostic Tests Players
Table 18. Global Viral Hepatitis and Retrovirus Diagnostic Tests Revenue by Players (2015-2020) (Million US$)
Table 19. Global Viral Hepatitis and Retrovirus Diagnostic Tests Market Share by Players (2015-2020)
Table 20. Global Top Viral Hepatitis and Retrovirus Diagnostic Tests Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Viral Hepatitis and Retrovirus Diagnostic Tests as of 2019)
Table 21. Global Viral Hepatitis and Retrovirus Diagnostic Tests by Players Market Concentration Ratio (CR5 and HHI)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Viral Hepatitis and Retrovirus Diagnostic Tests Product Solution and Service
Table 24. Date of Enter into Viral Hepatitis and Retrovirus Diagnostic Tests Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Viral Hepatitis and Retrovirus Diagnostic Tests Market Size by Type (2015-2020) (Million US$)
Table 27. Global Viral Hepatitis and Retrovirus Diagnostic Tests Market Size Share by Type (2015-2020)
Table 28. Global Viral Hepatitis and Retrovirus Diagnostic Tests Revenue Market Share by Type (2021-2026)
Table 29. Global Viral Hepatitis and Retrovirus Diagnostic Tests Market Size Share by Application (2015-2020)
Table 30. Global Viral Hepatitis and Retrovirus Diagnostic Tests Market Size by Application (2015-2020) (Million US$)
Table 31. Global Viral Hepatitis and Retrovirus Diagnostic Tests Market Size Share by Application (2021-2026)
Table 32. North America Key Players Viral Hepatitis and Retrovirus Diagnostic Tests Revenue (2019-2020) (Million US$)
Table 33. North America Key Players Viral Hepatitis and Retrovirus Diagnostic Tests Market Share (2019-2020)
Table 34. North America Viral Hepatitis and Retrovirus Diagnostic Tests Market Size by Type (2015-2020) (Million US$)
Table 35. North America Viral Hepatitis and Retrovirus Diagnostic Tests Market Share by Type (2015-2020)
Table 36. North America Viral Hepatitis and Retrovirus Diagnostic Tests Market Size by Application (2015-2020) (Million US$)
Table 37. North America Viral Hepatitis and Retrovirus Diagnostic Tests Market Share by Application (2015-2020)
Table 38. Europe Key Players Viral Hepatitis and Retrovirus Diagnostic Tests Revenue (2019-2020) (Million US$)
Table 39. Europe Key Players Viral Hepatitis and Retrovirus Diagnostic Tests Market Share (2019-2020)
Table 40. Europe Viral Hepatitis and Retrovirus Diagnostic Tests Market Size by Type (2015-2020) (Million US$)
Table 41. Europe Viral Hepatitis and Retrovirus Diagnostic Tests Market Share by Type (2015-2020)
Table 42. Europe Viral Hepatitis and Retrovirus Diagnostic Tests Market Size by Application (2015-2020) (Million US$)
Table 43. Europe Viral Hepatitis and Retrovirus Diagnostic Tests Market Share by Application (2015-2020)
Table 44. China Key Players Viral Hepatitis and Retrovirus Diagnostic Tests Revenue (2019-2020) (Million US$)
Table 45. China Key Players Viral Hepatitis and Retrovirus Diagnostic Tests Market Share (2019-2020)
Table 46. China Viral Hepatitis and Retrovirus Diagnostic Tests Market Size by Type (2015-2020) (Million US$)
Table 47. China Viral Hepatitis and Retrovirus Diagnostic Tests Market Share by Type (2015-2020)
Table 48. China Viral Hepatitis and Retrovirus Diagnostic Tests Market Size by Application (2015-2020) (Million US$)
Table 49. China Viral Hepatitis and Retrovirus Diagnostic Tests Market Share by Application (2015-2020)
Table 50. Japan Key Players Viral Hepatitis and Retrovirus Diagnostic Tests Revenue (2019-2020) (Million US$)
Table 51. Japan Key Players Viral Hepatitis and Retrovirus Diagnostic Tests Market Share (2019-2020)
Table 52. Japan Viral Hepatitis and Retrovirus Diagnostic Tests Market Size by Type (2015-2020) (Million US$)
Table 53. Japan Viral Hepatitis and Retrovirus Diagnostic Tests Market Share by Type (2015-2020)
Table 54. Japan Viral Hepatitis and Retrovirus Diagnostic Tests Market Size by Application (2015-2020) (Million US$)
Table 55. Japan Viral Hepatitis and Retrovirus Diagnostic Tests Market Share by Application (2015-2020)
Table 56. Southeast Asia Key Players Viral Hepatitis and Retrovirus Diagnostic Tests Revenue (2019-2020) (Million US$)
Table 57. Southeast Asia Key Players Viral Hepatitis and Retrovirus Diagnostic Tests Market Share (2019-2020)
Table 58. Southeast Asia Viral Hepatitis and Retrovirus Diagnostic Tests Market Size by Type (2015-2020) (Million US$)
Table 59. Southeast Asia Viral Hepatitis and Retrovirus Diagnostic Tests Market Share by Type (2015-2020)
Table 60. Southeast Asia Viral Hepatitis and Retrovirus Diagnostic Tests Market Size by Application (2015-2020) (Million US$)
Table 61. Southeast Asia Viral Hepatitis and Retrovirus Diagnostic Tests Market Share by Application (2015-2020)
Table 62. India Key Players Viral Hepatitis and Retrovirus Diagnostic Tests Revenue (2019-2020) (Million US$)
Table 63. India Key Players Viral Hepatitis and Retrovirus Diagnostic Tests Market Share (2019-2020)
Table 64. India Viral Hepatitis and Retrovirus Diagnostic Tests Market Size by Type (2015-2020) (Million US$)
Table 65. India Viral Hepatitis and Retrovirus Diagnostic Tests Market Share by Type (2015-2020)
Table 66. India Viral Hepatitis and Retrovirus Diagnostic Tests Market Size by Application (2015-2020) (Million US$)
Table 67. India Viral Hepatitis and Retrovirus Diagnostic Tests Market Share by Application (2015-2020)
Table 68. Central & South America Key Players Viral Hepatitis and Retrovirus Diagnostic Tests Revenue (2019-2020) (Million US$)
Table 69. Central & South America Key Players Viral Hepatitis and Retrovirus Diagnostic Tests Market Share (2019-2020)
Table 70. Central & South America Viral Hepatitis and Retrovirus Diagnostic Tests Market Size by Type (2015-2020) (Million US$)
Table 71. Central & South America Viral Hepatitis and Retrovirus Diagnostic Tests Market Share by Type (2015-2020)
Table 72. Central & South America Viral Hepatitis and Retrovirus Diagnostic Tests Market Size by Application (2015-2020) (Million US$)
Table 73. Central & South America Viral Hepatitis and Retrovirus Diagnostic Tests Market Share by Application (2015-2020)
Table 74. Abbott Diagnostics Company Details
Table 75. Abbott Diagnostics Business Overview
Table 76. Abbott Diagnostics Product
Table 77. Abbott Diagnostics Revenue in Viral Hepatitis and Retrovirus Diagnostic Tests Business (2015-2020) (Million US$)
Table 78. Abbott Diagnostics Recent Development
Table 79. Abbott Company Details
Table 80. Abbott Business Overview
Table 81. Abbott Product
Table 82. Abbott Revenue in Viral Hepatitis and Retrovirus Diagnostic Tests Business (2015-2020) (Million US$)
Table 83. Abbott Recent Development
Table 84. Chembio Company Details
Table 85. Chembio Business Overview
Table 86. Chembio Product
Table 87. Chembio Revenue in Viral Hepatitis and Retrovirus Diagnostic Tests Business (2015-2020) (Million US$)
Table 88. Chembio Recent Development
Table 89. DiaSorin Company Details
Table 90. DiaSorin Business Overview
Table 91. DiaSorin Product
Table 92. DiaSorin Revenue in Viral Hepatitis and Retrovirus Diagnostic Tests Business (2015-2020) (Million US$)
Table 93. DiaSorin Recent Development
Table 94. Roche Diagnostics Company Details
Table 95. Roche Diagnostics Business Overview
Table 96. Roche Diagnostics Product
Table 97. Roche Diagnostics Revenue in Viral Hepatitis and Retrovirus Diagnostic Tests Business (2015-2020) (Million US$)
Table 98. Roche Diagnostics Recent Development
Table 99. Amkay Products Company Details
Table 100. Amkay Products Business Overview
Table 101. Amkay Products Product
Table 102. Amkay Products Revenue in Viral Hepatitis and Retrovirus Diagnostic Tests Business (2015-2020) (Million US$)
Table 103. Amkay Products Recent Development
Table 104. AOV International Company Details
Table 105. AOV International Business Overview
Table 106. AOV International Product
Table 107. AOV International Revenue in Viral Hepatitis and Retrovirus Diagnostic Tests Business (2015-2020) (Million US$)
Table 108. AOV International Recent Development
Table 109. Apothecaries Sundries Manufacturing Business Overview
Table 110. Apothecaries Sundries Manufacturing Product
Table 111. Apothecaries Sundries Manufacturing Company Details
Table 112. Apothecaries Sundries Manufacturing Revenue in Viral Hepatitis and Retrovirus Diagnostic Tests Business (2015-2020) (Million US$)
Table 113. Apothecaries Sundries Manufacturing Recent Development
Table 114. Beckman Coulter Company Details
Table 115. Beckman Coulter Business Overview
Table 116. Beckman Coulter Product
Table 117. Beckman Coulter Revenue in Viral Hepatitis and Retrovirus Diagnostic Tests Business (2015-2020) (Million US$)
Table 118. Beckman Coulter Recent Development
Table 119. BD Company Details
Table 120. BD Business Overview
Table 121. BD Product
Table 122. BD Revenue in Viral Hepatitis and Retrovirus Diagnostic Tests Business (2015-2020) (Million US$)
Table 123. BD Recent Development
Table 124. Bhat Bio-tech Company Details
Table 125. Bhat Bio-tech Business Overview
Table 126. Bhat Bio-tech Product
Table 127. Bhat Bio-tech Revenue in Viral Hepatitis and Retrovirus Diagnostic Tests Business (2015-2020) (Million US$)
Table 128. Bhat Bio-tech Recent Development
Table 129. BioMerieux Company Details
Table 130. BioMerieux Business Overview
Table 131. BioMerieux Product
Table 132. BioMerieux Revenue in Viral Hepatitis and Retrovirus Diagnostic Tests Business (2015-2020) (Million US$)
Table 133. BioMerieux Recent Development
Table 134. Bioneovan Company Details
Table 135. Bioneovan Business Overview
Table 136. Bioneovan Product
Table 137. Bioneovan Revenue in Viral Hepatitis and Retrovirus Diagnostic Tests Business (2015-2020) (Million US$)
Table 138. Bioneovan Recent Development
Table 139. Bio-Rad Company Details
Table 140. Bio-Rad Business Overview
Table 141. Bio-Rad Product
Table 142. Bio-Rad Revenue in Viral Hepatitis and Retrovirus Diagnostic Tests Business (2015-2020) (Million US$)
Table 143. Bio-Rad Recent Development
Table 144. Cepheid Company Details
Table 145. Cepheid Business Overview
Table 146. Cepheid Product
Table 147. Cepheid Revenue in Viral Hepatitis and Retrovirus Diagnostic Tests Business (2015-2020) (Million US$)
Table 148. Cepheid Recent Development
Table 149. Enzo Biochem Company Details
Table 150. Enzo Biochem Business Overview
Table 151. Enzo Biochem Product
Table 152. Enzo Biochem Revenue in Viral Hepatitis and Retrovirus Diagnostic Tests Business (2015-2020) (Million US$)
Table 153. Enzo Biochem Recent Development
Table 154. Fujirebio Company Details
Table 155. Fujirebio Business Overview
Table 156. Fujirebio Product
Table 157. Fujirebio Revenue in Viral Hepatitis and Retrovirus Diagnostic Tests Business (2015-2020) (Million US$)
Table 158. Fujirebio Recent Development
Table 159. Gemc Technology Company Details
Table 160. Gemc Technology Business Overview
Table 161. Gemc Technology Product
Table 162. Gemc Technology Revenue in Viral Hepatitis and Retrovirus Diagnostic Tests Business (2015-2020) (Million US$)
Table 163. Gemc Technology Recent Development
Table 164. Grifols Company Details
Table 165. Grifols Business Overview
Table 166. Grifols Product
Table 167. Grifols Revenue in Viral Hepatitis and Retrovirus Diagnostic Tests Business (2015-2020) (Million US$)
Table 168. Grifols Recent Development
Table 169. Hangzhou Deangel Biological Engineering Company Details
Table 170. Hangzhou Deangel Biological Engineering Business Overview
Table 171. Hangzhou Deangel Biological Engineering Product
Table 172. Hangzhou Deangel Biological Engineering Revenue in Viral Hepatitis and Retrovirus Diagnostic Tests Business (2015-2020) (Million US$)
Table 173. Hangzhou Deangel Biological Engineering Recent Development
Table 174. Hangzhou Heo Bio-Tech Company Details
Table 175. Hangzhou Heo Bio-Tech Business Overview
Table 176. Hangzhou Heo Bio-Tech Product
Table 177. Hangzhou Heo Bio-Tech Revenue in Viral Hepatitis and Retrovirus Diagnostic Tests Business (2015-2020) (Million US$)
Table 178. Hangzhou Heo Bio-Tech Recent Development
Table 179. Hologic Company Details
Table 180. Hologic Business Overview
Table 181. Hologic Product
Table 182. Hologic Revenue in Viral Hepatitis and Retrovirus Diagnostic Tests Business (2015-2020) (Million US$)
Table 183. Hologic Recent Development
Table 184. Horiba Company Details
Table 185. Horiba Business Overview
Table 186. Horiba Product
Table 187. Horiba Revenue in Viral Hepatitis and Retrovirus Diagnostic Tests Business (2015-2020) (Million US$)
Table 188. Horiba Recent Development
Table 189. Innovation Biotech Company Details
Table 190. Innovation Biotech Business Overview
Table 191. Innovation Biotech Product
Table 192. Innovation Biotech Revenue in Viral Hepatitis and Retrovirus Diagnostic Tests Business (2015-2020) (Million US$)
Table 193. Innovation Biotech Recent Development
Table 194. Jaksh Enterprises Company Details
Table 195. Jaksh Enterprises Business Overview
Table 196. Jaksh Enterprises Product
Table 197. Jaksh Enterprises Revenue in Viral Hepatitis and Retrovirus Diagnostic Tests Business (2015-2020) (Million US$)
Table 198. Jaksh Enterprises Recent Development
Table 199. Krishco Medical Products Company Details
Table 200. Krishco Medical Products Business Overview
Table 201. Krishco Medical Products Product
Table 202. Krishco Medical Products Revenue in Viral Hepatitis and Retrovirus Diagnostic Tests Business (2015-2020) (Million US$)
Table 203. Krishco Medical Products Recent Development
Table 204. Research Programs/Design for This Report
Table 205. Key Data Information from Secondary Sources
Table 206. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Viral Hepatitis and Retrovirus Diagnostic Tests Market Share by Type: 2020 VS 2026
Figure 2. Acute Hepatitis Features
Figure 3. Chronic Hepatitis Features
Figure 4. Global Viral Hepatitis and Retrovirus Diagnostic Tests Market Share by Application: 2020 VS 2026
Figure 5. Hospitals Case Studies
Figure 6. Clinics Case Studies
Figure 7. Home Nursing Case Studies
Figure 8. Viral Hepatitis and Retrovirus Diagnostic Tests Report Years Considered
Figure 9. Global Viral Hepatitis and Retrovirus Diagnostic Tests Market Size YoY Growth 2015-2026 (US$ Million)
Figure 10. Global Viral Hepatitis and Retrovirus Diagnostic Tests Market Share by Regions: 2020 VS 2026
Figure 11. Global Viral Hepatitis and Retrovirus Diagnostic Tests Market Share by Regions (2021-2026)
Figure 12. Porter's Five Forces Analysis
Figure 13. Global Viral Hepatitis and Retrovirus Diagnostic Tests Market Share by Players in 2019
Figure 14. Global Top Viral Hepatitis and Retrovirus Diagnostic Tests Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Viral Hepatitis and Retrovirus Diagnostic Tests as of 2019
Figure 15. The Top 10 and 5 Players Market Share by Viral Hepatitis and Retrovirus Diagnostic Tests Revenue in 2019
Figure 16. North America Viral Hepatitis and Retrovirus Diagnostic Tests Market Size YoY Growth (2015-2020) (Million US$)
Figure 17. Europe Viral Hepatitis and Retrovirus Diagnostic Tests Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. China Viral Hepatitis and Retrovirus Diagnostic Tests Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Japan Viral Hepatitis and Retrovirus Diagnostic Tests Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Southeast Asia Viral Hepatitis and Retrovirus Diagnostic Tests Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. India Viral Hepatitis and Retrovirus Diagnostic Tests Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Central & South America Viral Hepatitis and Retrovirus Diagnostic Tests Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Bottom-up and Top-down Approaches for This Report
Figure 24. Data Triangulation
Figure 25. Key Executives Interviewed
E型肝炎診断検査の世界市場（～2026年） Hepatitis E is a virus that affects your liver. Market Analysis and Insights: Global Hepatitis E Diagnostic Tests Market The global Hepatitis E Diagnostic Tests market size is projected to reach US$ 43 million by 2026, from US$ 42 million in 2020, at a CAGR of 2.2%% during 2021-2026. Global Hepatiti…- B型肝炎診断検査の世界市場（～2026年） Market Analysis and Insights: Global Hepatitis B Diagnostic Tests Market The global Hepatitis B Diagnostic Tests market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Hepatitis B Diagnostic Tests Scope and Market Size Hepati…
- 肝炎ウイルス診断検査の世界市場（～2026年） Market Analysis and Insights: Global Hepatitis Viruses Diagnostic Tests Market The global Hepatitis Viruses Diagnostic Tests market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Hepatitis Viruses Diagnostic Tests Scope and …
- 肝炎診断検査の世界市場（～2026年） Hepatitis is a medical condition characterized by inflammation of the liver which often leads to other complications such as jaundice, anorexia, liver failure and cirrhosis. Hepatitis is generally of two types- acute when it lasts for less than six months and chronic when it lasts for longer period.…
- 肝炎検査ソリューションの世界市場（～2026年） Hepatitis is generally classified into two types based on the duration for which the patient suffers. If the condition lasts for less than six months, then it is classified as acute, when the condition persists for more than six months, then it is a case of chronic condition. Hepatitis testing refer…